Richelle Mychasiuk

Dr. Richelle Mychasiuk

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2017 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
DWDavid K. Wright
David K. Wright
TOTerence J. O'BRien
Terence J. O'BRien
SSSandy R. Shultz
Sandy R. Shultz
RMRichelle Mychasiuk
Richelle Mychasiuk
Objective: Whether sex differences contribute to the heterogeneity of mild traumatic brain injury (mTBI) and repeated mTBI (RmTBI) outcomes in adolescents is unknown. Therefore, this study examined changes in, and differences between, male and female rats following single mTBI and RmTBI.Methods: Rats were given a single mTBI, RmTBI (i.e., 3x), or sham injuries. Injuries were administered using a lateral impact model that mimics forces common in human mTBI. After the final injury, rats underwent extensive behavioral testing to examine cognition, motor function, and anxiety‐ and depressive‐like behavior. Postmortem analyses investigated gene expression and structural changes in the brain.Results: Many of the outcomes exhibited a sex‐dependent response to RmTBI. While all rats given RmTBI had deficits in balance, motor coordination, locomotion, and anxiety‐like behavior, only male rats given RmTBI had short‐term working memory deficits, whereas only females given RmTBI had increased depressive‐like behavior. Volumetric and diffusion weighted MRI analyses found that while RmTBI‐induced atrophy of the prefrontal cortex was greater in female rats, only the male rats exhibited worse white matter integrity in the corpus callosum following RmTBI. Sex‐dependent changes in brain expression of mRNA for glial fibrillary acidic protein, myelin basic protein, and tau protein were also observed following injury.Interpretation: These findings suggest that in adolescent mTBI, sex matters; and future studies incorporating both male and females are warranted to provide a greater understanding of injury prognosis and better inform clinical practice.

1 January 2016 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
RMRichelle Mychasiuk
Richelle Mychasiuk
HHHarleen Hehar
Harleen Hehar
SCSydeny Candy
Sydeny Candy
IMIrene Ma
Irene Ma
MEMichael J. Esser
Michael J. Esser

1 March 2021 in Progress in Neurobiology
Verified
Journal Article
Closed access
JCJennaya Christensen
Jennaya Christensen
GYGlenn R. Yamakawa
Glenn R. Yamakawa
SSSandy R. Shultz
Sandy R. Shultz
RMRichelle Mychasiuk
Richelle Mychasiuk

10 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JCJennaya Christensen
Jennaya Christensen
DWDavid K. Wright
David K. Wright
GYGlenn R. Yamakawa
Glenn R. Yamakawa
SSSandy R. Shultz
Sandy R. Shultz
RMRichelle Mychasiuk
Richelle Mychasiuk
The glymphatic system is the macroscopic waste clearance system for the central nervous system. Glymphatic dysfunction has been linked to several neurological conditions, including traumatic brain injury (TBI). Adolescents are at particularly high risk for experiencing a TBI, particularly mild TBI (mTBI) and repetitive mTBI (RmTBI); however, glymphatic clearance, and how it relates to behavioral outcomes, has not been investigated in this context. Therefore, this study examined glymphatic function in the adolescent brain following RmTBI. Female adolescent Sprague Dawley rats were subjected to either three mTBIs or sham injuries spaced three days apart. One-day after their final injury, the animals underwent a beam walking task to assess sensorimotor function, and contrast-enhanced MRI to visualize glymphatic clearance rate. Behavioural measures indicated that the RmTBI group displayed an increase in loss of consciousness as well as motor coordination and balance deficits consistent with our previous studies. The contrast-enhanced MRI results indicated that the female adolescent glymphatic system responds to RmTBI in a region-specific manner, wherein an increased influx but reduced efflux was observed throughout limbic structures (hypothalamus, hippocampus, and amygdala) and the olfactory bulb but neither the influx or efflux were altered in the cortical structures (primary motor cortex, insular cortex, and dorsolateral prefrontal cortex) examined. This may indicate a role for an impaired and/or inefficient glymphatic system in the limbic structures and cortical structures, respectively, in the development of post-concussive symptomology during adolescence.

11 October 2011 in Child: Care, Health and Development
Verified
Journal Article
Closed access
PDF file
RMRichelle Mychasiuk
Richelle Mychasiuk
Karen BenziesKaren Benzies
Karen Benzies

17 March 2022 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
JCJennaya Christensen
Jennaya Christensen
CLCrystal Li
Crystal Li
RMRichelle Mychasiuk
Richelle Mychasiuk
As research regarding the role of circadian rhythms, sleep, and the orexinergic system in neurodegenerative diseases is growing, it is surprising that the choroid plexus (CP) remains underappreciated in this realm. Despite its extensive role in the regulation of circadian rhythms and orexinergic signalling, as well as acting as the primary conduit between cerebrospinal fluid (CSF) and the circulatory system, providing a mechanism by which toxic waste molecules can be removed from the brain, the CP has been largely unexplored in neurodegeneration. In this review, we explore the role of the CP in maintaining brain homeostasis and circadian rhythms, regulating CSF dynamics, and how these functions change across the lifespan, from development to senescence. In addition, we examine the relationship between the CP, orexinergic signalling, and the glymphatic system, highlighting gaps in the literature and areas that require immediate exploration. Finally, we assess current knowledge, including possible therapeutic strategies, regarding the role of the CP in neurological disorders, such as traumatic brain injury, migraine, Alzheimer’s disease, and multiple sclerosis.